Thomson Reuters ONE/Neue Daten Aus -2-

Published September 13, 2013

Thomson Reuters ONE/Neue Daten aus -2-
The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist. … PLOS ONE 7(10): e47662. doi:10.1371/journal.pone.0047662 5 … Read more on Finanzen.net